Armistice Capital
Armistice Capital reported 333 stocks worth $3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are SUPN (3.7%), AGIO (2.9%) and PTCT (2.8%). Compared with Q2 2026, the fund opened new positions in TLX, GEHC and BNTX, added to AGIO, PTCT and NBIX, trimmed SUPN, CYTK and TVTX and sold out of HUM, ILMN and PBH.
Latest filing: what Armistice Capital did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() SUPN Supernus Pharmaceuticals Inc | $110M | 3.7% | 2.5M | −98K (−4%) | 8 of 8 | |
| 2 | ![]() AGIO Agios Pharmaceuticals Inc | $85.7M | 2.9% | 2.6M | +178K (+7%) | 8 of 8 | |
| 3 | ![]() PTCT Ptc Therapeutics Inc | $84.1M | 2.8% | 1.3M | +226K (+21%) | 8 of 8 | |
| 4 | ![]() NBIX Neurocrine Biosciences Inc | $80.2M | 2.7% | 565K | +29K (+5%) | 8 of 8 | |
| 5 | ![]() CYTK Cytokinetics Inc | $77.8M | 2.6% | 1.2M | −21K (−2%) | 8 of 8 | |
| 6 | ![]() TVTX Travere Therapeutics Inc | $75.9M | 2.5% | 1.3M | −283K (−18%) | 8 of 8 | |
| 7 | ![]() RIGL Rigel Pharmaceuticals Inc | $74M | 2.5% | 1.5M | −136K (−8%) | 8 of 8 | |
| 8 | ![]() INCY Incyte Corp | $72.8M | 2.4% | 600K | −300K (−33%) | 8 of 8 | |
| 9 | ![]() IRWD Ironwood Pharmaceuticals Inc | $59.5M | 2.0% | 15M | +1.1M (+8%) | 8 of 8 | |
| 10 | ![]() IMVT Immunovant Inc | $58.7M | 2.0% | 1.7M | +2,169 (+0%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() HUM Humana Inc | $28.8M | 73K |
![]() ILMN Illumina Inc | $16M | 91K |
![]() PBH Prestige Consmr Healthcare I | $15.9M | 336K |
![]() FWONK Liberty Media Corp Del | $15.7M | 165K |
![]() ITGR Integer Hldgs Corp | $15.7M | 168K |
🔒 Free account: see all 30.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() SPY Spdr S&P 500 ETF TR | Call | $2.6B | 3.4M | +3,350,000 |
![]() IWM Ishares TR | Call | $1.8B | 6.6M | +6,600,000 |
![]() CYTK Cytokinetics Inc | Call | $169M | 2.6M | +1,030,000 |
![]() MDGL Madrigal Pharmaceuticals Inc | Call | $129M | 255K | +255,000 |
![]() AGIO Agios Pharmaceuticals Inc | Call | $110M | 3.3M | +495,100 |
🔒 Free account: see all 13.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Armistice Capital 13F FAQ
What does Armistice Capital own?
Armistice Capital reported 333 stocks worth $3B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are SUPN (3.7%), AGIO (2.9%) and PTCT (2.8%). The table above lists every position in the filing (the top 10 without an account).
What did Armistice Capital buy and sell in Q3 2026?
Compared with Q2 2026: 158 new positions, 69 added to, 83 trimmed and 148 sold out. New positions include TLX, GEHC and BNTX. It sold all of HUM, ILMN and PBH.
When will Armistice Capital file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Armistice Capital's portfolio worth?
The Q3 2026 filing reports $3B in US stocks ($8.2B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.





























